摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

(R)-2-(3-amino-1-phenylpropoxy)-5-chlorobenzonitrile fumarate | 1308270-76-9

中文名称
——
中文别名
——
英文名称
(R)-2-(3-amino-1-phenylpropoxy)-5-chlorobenzonitrile fumarate
英文别名
2-[(1R)-3-amino-1-phenylpropoxy]-5-chlorobenzonitrile
(R)-2-(3-amino-1-phenylpropoxy)-5-chlorobenzonitrile fumarate化学式
CAS
1308270-76-9
化学式
C16H15ClN2O
mdl
——
分子量
286.761
InChiKey
BGXQGNICDPIKQK-MRXNPFEDSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    3.2
  • 重原子数:
    20
  • 可旋转键数:
    5
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.19
  • 拓扑面积:
    59
  • 氢给体数:
    1
  • 氢受体数:
    3

反应信息

  • 作为反应物:
    描述:
    (R)-2-(3-amino-1-phenylpropoxy)-5-chlorobenzonitrile fumarate富马酸 生成 2-[(1R)-3-amino-1-phenylpropoxy]-5-chlorobenzonitrile;(E)-but-2-enedioic acid
    参考文献:
    名称:
    The discovery of novel, potent and highly selective inhibitors of inducible nitric oxide synthase (iNOS)
    摘要:
    By careful analysis of experimental X-ray ligand crystallographic protein data across several inhibitor series we have discovered a novel, potent and selective series of iNOS inhibitors exemplified by compound 8. (C) 2011 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.bmcl.2011.02.061
  • 作为产物:
    描述:
    在 sodium azide 、 三苯基膦 作用下, 以 四氢呋喃二甲基亚砜 为溶剂, 反应 17.0h, 生成 (R)-2-(3-amino-1-phenylpropoxy)-5-chlorobenzonitrile fumarate
    参考文献:
    名称:
    The discovery of novel, potent and highly selective inhibitors of inducible nitric oxide synthase (iNOS)
    摘要:
    By careful analysis of experimental X-ray ligand crystallographic protein data across several inhibitor series we have discovered a novel, potent and selective series of iNOS inhibitors exemplified by compound 8. (C) 2011 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.bmcl.2011.02.061
点击查看最新优质反应信息

文献信息

  • Selective Inhibitors Of i-NOS For Use Against Viral Infection
    申请人:UCL Business PLC
    公开号:US20180214430A1
    公开(公告)日:2018-08-02
    The present invention concerns compounds for use in the prevention of viral replication and/or the prevention or treatment of a viral infection, wherein the compounds are selective inhibitors of inducible nitric oxide synthase, and methods of preventing viral replication and/or preventing or treating viral infections in a subject comprising administering a prophylactically or therapeutically effective amount of the compounds.
  • The discovery of novel, potent and highly selective inhibitors of inducible nitric oxide synthase (iNOS)
    作者:David R. Cheshire、Anders Åberg、Gunilla M.K. Andersson、Glen Andrews、Haydn G. Beaton、Timothy N. Birkinshaw、Nigel Boughton-Smith、Stephen Connolly、Tony R. Cook、Anne Cooper、Sally L. Cooper、David Cox、John Dixon、Nigel Gensmantel、Peter J. Hamley、Richard Harrison、Paul Hartopp、Helena Käck、Paul D. Leeson、Timothy Luker、Antonio Mete、Ian Millichip、David J. Nicholls、Austen D. Pimm、Steve A. St-Gallay、Alan V. Wallace
    DOI:10.1016/j.bmcl.2011.02.061
    日期:2011.4
    By careful analysis of experimental X-ray ligand crystallographic protein data across several inhibitor series we have discovered a novel, potent and selective series of iNOS inhibitors exemplified by compound 8. (C) 2011 Elsevier Ltd. All rights reserved.
查看更多